BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18029075)

  • 1. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications.
    Leggio L; Kenna GA; Swift RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1106-17. PubMed ID: 18029075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
    Ait-Daoud N; Malcolm RJ; Johnson BA
    Addict Behav; 2006 Sep; 31(9):1628-49. PubMed ID: 16472931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
    Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid management of acute alcohol withdrawal.
    Lum E; Gorman SK; Slavik RS
    Ann Pharmacother; 2006 Mar; 40(3):441-8. PubMed ID: 16507623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of pharmacological approaches in the treatment of alcohol withdrawal syndrome (AWS): a literature review.
    Cooper E; Vernon J
    J Psychiatr Ment Health Nurs; 2013 Sep; 20(7):601-12. PubMed ID: 22989012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
    Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
    W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcohol withdrawal--biological background, diagnosis and treatment].
    Johnsen J; Mørland J
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1528-32. PubMed ID: 1971124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medications acting on the GABA system in the treatment of alcoholic patients.
    Caputo F; Bernardi M
    Curr Pharm Des; 2010; 16(19):2118-25. PubMed ID: 20482512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and therapeutic aspects of alcohol withdrawal syndrome].
    Miniati M; Bani A; Mauri M
    Minerva Psichiatr; 1993 Sep; 34(3):173-9. PubMed ID: 8302190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
    Coskun O; Ucler S; Cavdar L; Inan LE
    J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
    Barrons R; Roberts N
    J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbamazepine in the treatment of alcohol withdrawal].
    Wolańczyk T; Wojnar M; Cedro A
    Psychiatr Pol; 1997; 31(2):189-96. PubMed ID: 9527664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol withdrawal syndrome.
    Bayard M; McIntyre J; Hill KR; Woodside J
    Am Fam Physician; 2004 Mar; 69(6):1443-50. PubMed ID: 15053409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benzodiazepines in the treatment of alcoholism].
    Ades J; Rodière C
    Encephale; 1983; 9(4 Suppl 2):293B-298B. PubMed ID: 6373235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.
    Smith JT; Sage M; Szeto H; Myers LC; Lu Y; Martinez A; Kipnis P; Liu VX
    JAMA Netw Open; 2022 Feb; 5(2):e220158. PubMed ID: 35191968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.